These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group]. Ames D, Camm J, Cook P, Falkai P, Gury C, Hurley R, Johnson G, Piepho R, Vieweg V, Cardiac Safety in Schizophrenia Group. Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268 [Abstract] [Full Text] [Related]
13. [Drug-induced arrhythmia a difficult to catch adverse effect. New guidelines for increased cardiovascular safety]. Darpö B. Lakartidningen; 2002; 103(14):1094-5. PubMed ID: 16681092 [No Abstract] [Full Text] [Related]
14. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia]. Gury C, Canceil O, Iaria P. Encephale; 2000; 26(6):62-72. PubMed ID: 11217540 [Abstract] [Full Text] [Related]